cerus.com (CERS): Rentabilitas operasi

Cerus Corporation (CERS) - logo korporat

Cerus Corporation (CERS) relies on competent management and the transparent revenue system of Intercept. Business development is based on the implementation of blood purification technologies in medical centers. Financial stability is supported by government procurement of anti-viral systems. Meanwhile, the value of -12.20 reflects the metric balance, which is clearly demonstrated by the actual operating margin.

CERS - Rasio bathi operasi Cerus ing rentang 04.07.2022 - 20.11.2026

Rincian analitis perusahaan Cerus Corporation

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
Analisis fundamental perusahaan:CERS, Cerus Corp
Produk dadi Cerus Inc

Minimizing fundamental risks requires selecting assets with a sustainable ability to generate cash flow. This metric reflects the share of operating profit in total revenue, excluding the impact of debt load and the tax regime. For Cerus Corporation (CERS), this is an indicator of the scaling efficiency of INTERCEPT systems within the hospital sector. Analyzing the operating margin before taxes and interest allows for an assessment of the real profitability of key technologies. The operating margin trend before taxes and interest reveals the business's adaptability to market stresses.

Analisis pesaing Cerus Corporation

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Margin dodolan operasi ICU Medical Corp (ICUI)|Rentabilitas operasi DENTSPLY SIRONA Inc. (XRAY)|Margin dodolan operasi LeMaitre LMAT|Margin operasi ATRC (atricure.com)|Margin operasi staar.com STAA|NAGE - Rentabilitas operasi|Rentabilitas kegiatan operasi ZimVie ZIMV|ANGO: Margin operasi|Alpha Teknova, Inc. - Tingkat bathi operasi|MGRM (Monogram Orthopedics Inc.) - Margin operasi|STSS: Tingkat bathi operasi|Margin dodolan operasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Rentabilitas dodolan miturut bathi operasi|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi